• Ex-Biogen manager claims she was fired after filing integrity complaint fiercepharma
    July 31, 2018
    Biogen didn't have much success on the market with multiple sclerosis med Zinbryta, and now the drug is at the center of a discrimination and retaliation lawsuit by a former manager.
  • EMA confirms risks of MS drug Zinbryta pharmatimes
    May 24, 2018
    The Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that Zinbryta (daclizumab) “poses a risk of serious and potentially fatal immune reactions affecting the brain, liver and other organs.”
PharmaSources Customer Service